Biomx Inc
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Stock Performance Snapshot
Analyst Rating
Analysts are optimistic about Biomx's stock, recommending a buy with a target price of $22.
Financial Health
Biomx Inc shows solid cash flow and book value, indicating a strong financial position.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring PHGE
Microbiome Modulators
Discover a carefully selected group of innovative biotechnology companies leveraging the untapped power of the body's microbiome. These pioneering firms are creating revolutionary therapies that target the root causes of disease by rebalancing our internal microbial ecosystems.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Small‑Cap Dynamics
Micro‑cap status can mean big price moves on limited news; useful for active research but expect higher volatility and lower liquidity.
Binary Catalysts Matter
Clinical or regulatory announcements (if applicable) and financing rounds can sharply move the stock—though outcomes are uncertain and can be negative.
Do your research
Review filings, cash runway and management commentary; consider independent analysis and whether this risk profile suits your diversification needs.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
